According to a new market research report "Smart Pills Market by Application (Capsule Endoscopy, Drug Delivery, Patient Monitoring), by Target Area (Esophagus, Stomach, Small Intestine, Large Intestine), by Geography - Global Forecast to 2024 ", published by MarketsandMarkets, the Smart Pills Market is expected to reach around $8.98 Billion by 2024, growing at a CAGR of 16.16% 2014 - 2020 & CAGR of 23.7% 2020 - 2024.
Browse 67 market data Tables and 29 Figures spread through 200 Pages and in-depth TOC on "Smart Pills Market"
Early buyers will receive 10% customization on this report.
The North American market commanded the largest share of the global Smart Pills Market in 2014. The Asian market, on the other hand, is relatively new, and the increasing reimbursements, training in endoscopes handling, and huge corporate investments in R&D in countries like Japan will drive the growth of this market.
Download FREE PDF BROCHURE: https://www.marketsandmarkets.com/pdfdownload.asp?id=840
The major players in the global Smart Pills Market are CapsoVision, Inc. (U.S.), Given Imaging, Inc. (Israel), Medimetrics S.A. de C.V. (Mexico), Olympus Corporation (Japan), and Bio-Images Research Limited (U.K.).
The Smart Pills Market is segmented on the basis of applications and regions. On the basis of applications, the market is categorized into capsule endoscopy, drug delivery, and patient monitoring. On the basis of regions, the market is divided into North America, Europe, Asia, and Rest of the World (RoW: Pacific countries, Africa, and Latin America)
Full Press Release : https://www.marketsandmarkets.com/PressReleases/smart-pill.asp
The major factors driving the Smart Pills Market are favorable reimbursement scenario across the globe, patient preference for minimally invasive procedures, and rising prevalence of colon cancer. Moreover, benefits provided by the smart pills technology such as increased sophistication in endoscopy procedures, controlled drug delivery, and remote patient monitoring are resulting in the increasing adoption of smart pills technology. However, technological incompetence of capsule endoscopes, high costs, and fear among patients regarding swallowing a microchip are restraining the growth of this market.